Collectively, these findings demonstrate that TP5 exhibits consistent and potent antitumor activity across multiple cancer models, suggesting a fundamental mechanism of action that transcends tumor-specific characteristics and positioning TP5 as a promising broad-spectrum anticancer therapeutic agent. Here, TMPO is linked to cancer.